r for $ 32 million.
According to the representative of CSIR, a contract with the Bushmen to be signed before the end of the month, but the specific conditions are not yet clear. Most likely, they will get not so much because CSIR receives only 10 percent of the profits of the company Phytopharm, which in turn will receive only a percentage of Pfizer.
While the dasg is on the P57 first stage of clinical trials, the results are expected to announce on December 5. The second phase is planned for 2002, a year later is expected to begin a long third phase. With a little luck, the market P57 will appear in 2005 or 2006.
Source: Lenta.Ru 